Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2018

Open Access 01-12-2018 | Case Report

Single metastasis of myxoid liposarcoma from the thigh to thyroid gland: a case report

Authors: Hiroshi Urakawa, Kenichi Nakanishi, Eisuke Arai, Kunihiro Ikuta, Shunsuke Hamada, Takehiro Ota, Naoki Ishiguro, Yoshihiro Nishida

Published in: World Journal of Surgical Oncology | Issue 1/2018

Login to get access

Abstract

Background

Thyroid metastasis of soft tissue sarcoma is very rare, and the diagnosis is especially difficult when only a single lesion is present.

Case presentation

A 50-year-old man was diagnosed with myxoid liposarcoma of the right thigh and treated with wide resection. Two and a half years after the surgery, a growing low-density area was incidentally observed in the right lobe of his thyroid gland on follow-up chest computed tomography. Fine needle aspiration biopsy was performed twice, and the thyroid mass was suspected of being a sarcoma metastasis. He was treated by hemithyroidectomy, and the lesion was pathologically confirmed as a metastasis of myxoid liposarcoma.

Conclusion

We experienced single thyroid gland metastasis in patients with myxoid liposarcoma in whom a growing mass is observed in the thyroid gland after radical surgery of the primary site.
Literature
1.
go back to reference Ishikawa M, Hirano S, Tsuji T, Ito J. Management of metastasis to the thyroid gland. Auris Nasus Larynx. 2011;38:426–30.CrossRefPubMed Ishikawa M, Hirano S, Tsuji T, Ito J. Management of metastasis to the thyroid gland. Auris Nasus Larynx. 2011;38:426–30.CrossRefPubMed
2.
go back to reference Wood K, Vini L, Harmer C. Metastases to the thyroid gland: the Royal Marsden experience. Eur J Surg Oncol. 2004;30:583–8.CrossRefPubMed Wood K, Vini L, Harmer C. Metastases to the thyroid gland: the Royal Marsden experience. Eur J Surg Oncol. 2004;30:583–8.CrossRefPubMed
3.
go back to reference Moreau LC, Turcotte R, Ferguson P, Wunder J, Clarkson P, Masri B, Isler M, Dion N, Werier J, Ghert M, Deheshi B, S. Canadian Orthopaedic Oncology. Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases. Ann Surg Oncol. 2012;19:1081–8.CrossRefPubMed Moreau LC, Turcotte R, Ferguson P, Wunder J, Clarkson P, Masri B, Isler M, Dion N, Werier J, Ghert M, Deheshi B, S. Canadian Orthopaedic Oncology. Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases. Ann Surg Oncol. 2012;19:1081–8.CrossRefPubMed
4.
go back to reference Schwab JH, Boland P, Guo T, Brennan MF, Singer S, Healey JH, Antonescu CR. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread. Ann Surg Oncol. 2007;14:1507–14.CrossRefPubMed Schwab JH, Boland P, Guo T, Brennan MF, Singer S, Healey JH, Antonescu CR. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread. Ann Surg Oncol. 2007;14:1507–14.CrossRefPubMed
5.
go back to reference Bashir H, Nawaz MK, Shah MA, Ahmad E. Pleomorphic liposarcoma metastatic to the thyroid gland. Clin Nucl Med. 2002;27:9–10.CrossRefPubMed Bashir H, Nawaz MK, Shah MA, Ahmad E. Pleomorphic liposarcoma metastatic to the thyroid gland. Clin Nucl Med. 2002;27:9–10.CrossRefPubMed
6.
go back to reference Azar AR, Weynand B, Daumerie C, Coche E. Metastatic liposarcoma of the thyroid gland. Br J Radiol. 2003;76:750–2.CrossRefPubMed Azar AR, Weynand B, Daumerie C, Coche E. Metastatic liposarcoma of the thyroid gland. Br J Radiol. 2003;76:750–2.CrossRefPubMed
7.
go back to reference Brandwein-Gensler M, Urken M, Wang B. Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head & neck. 2004;26:637–41.CrossRef Brandwein-Gensler M, Urken M, Wang B. Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head & neck. 2004;26:637–41.CrossRef
8.
go back to reference Tysome JR, Sandison A, Clarke PM. Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review. J Laryngol Otol. 2006;120:511–3.PubMed Tysome JR, Sandison A, Clarke PM. Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review. J Laryngol Otol. 2006;120:511–3.PubMed
9.
go back to reference Vankalakunti M, Kaur J, Srinivasan R. Cytology of sarcoma metastasizing to the thyroid: a case report. Acta Cytol. 2008;52:729–32.CrossRefPubMed Vankalakunti M, Kaur J, Srinivasan R. Cytology of sarcoma metastasizing to the thyroid: a case report. Acta Cytol. 2008;52:729–32.CrossRefPubMed
10.
go back to reference Tegler L, Gillquist J, Anderberg B, Lundstrom B, Johansson H. Thyroid blood flow rate in man. Electromagnetic flowmetry during operation in euthyroid normal gland, nontoxic goiter, and hyperthyroidism. J Endocrinol Invest. 1981;4:335–41.CrossRefPubMed Tegler L, Gillquist J, Anderberg B, Lundstrom B, Johansson H. Thyroid blood flow rate in man. Electromagnetic flowmetry during operation in euthyroid normal gland, nontoxic goiter, and hyperthyroidism. J Endocrinol Invest. 1981;4:335–41.CrossRefPubMed
11.
go back to reference Nishida Y, Tsukushi S, Nakashima H, Ishiguro N. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall. Clin Orthop Relat Res. 2010;468:3041–6.CrossRefPubMedPubMedCentral Nishida Y, Tsukushi S, Nakashima H, Ishiguro N. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall. Clin Orthop Relat Res. 2010;468:3041–6.CrossRefPubMedPubMedCentral
12.
go back to reference Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid : offi jl Am Thyroid Assoc. 2016;26:1–133.CrossRef Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid : offi jl Am Thyroid Assoc. 2016;26:1–133.CrossRef
13.
go back to reference Higgins CB, Auffermann W. MR imaging of thyroid and parathyroid glands: a review of current status. AJR Am J Roentgenol. 1988;151:1095–106.CrossRefPubMed Higgins CB, Auffermann W. MR imaging of thyroid and parathyroid glands: a review of current status. AJR Am J Roentgenol. 1988;151:1095–106.CrossRefPubMed
14.
go back to reference Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid : offi j Am Thyroid Assoc. 1998;8:15–21.CrossRef Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid : offi j Am Thyroid Assoc. 1998;8:15–21.CrossRef
15.
go back to reference Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid : offi j Am Thyroid Assoc. 1998;8:283–9.CrossRef Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid : offi j Am Thyroid Assoc. 1998;8:283–9.CrossRef
16.
go back to reference Urakawa H, Kozawa E, Ikuta K, Hamada S, Ishiguro N, Nishida Y. Impact of disease free status on prognosis in metastatic non-small round cell soft tissue sarcomas. Clinical & experimental metastasis. 2016;33:799–807.CrossRef Urakawa H, Kozawa E, Ikuta K, Hamada S, Ishiguro N, Nishida Y. Impact of disease free status on prognosis in metastatic non-small round cell soft tissue sarcomas. Clinical & experimental metastasis. 2016;33:799–807.CrossRef
17.
go back to reference Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.CrossRefPubMed Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.CrossRefPubMed
18.
go back to reference Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J, Hogendoorn PC, Ouali M, Marreaud S, Bramwell VH, Hohenberger P, Tissue ES, Bone Sarcoma G, N.C.T.G.S.D.S.C. the. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13:1045–54.CrossRefPubMed Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J, Hogendoorn PC, Ouali M, Marreaud S, Bramwell VH, Hohenberger P, Tissue ES, Bone Sarcoma G, N.C.T.G.S.D.S.C. the. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13:1045–54.CrossRefPubMed
19.
go back to reference Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bague S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18:812–22.CrossRefPubMed Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bague S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18:812–22.CrossRefPubMed
20.
go back to reference Judson I, Verweij J, Gelderblom H, Hartmann JT, Schoffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litiere S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT, O. European, T. Treatment of Cancer Soft, G. Bone Sarcoma. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15:415–23.CrossRefPubMed Judson I, Verweij J, Gelderblom H, Hartmann JT, Schoffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litiere S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT, O. European, T. Treatment of Cancer Soft, G. Bone Sarcoma. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15:415–23.CrossRefPubMed
21.
go back to reference Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marples M, Veal GJ, Jamieson D, Kuver K, Tirabosco R, Forsyth S, Nash S, Dehbi HM, Beare S. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncol. 2017;18:1397–410.CrossRefPubMedPubMedCentral Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marples M, Veal GJ, Jamieson D, Kuver K, Tirabosco R, Forsyth S, Nash S, Dehbi HM, Beare S. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncol. 2017;18:1397–410.CrossRefPubMedPubMedCentral
22.
go back to reference Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res. 2012;2:2.CrossRefPubMedPubMedCentral Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res. 2012;2:2.CrossRefPubMedPubMedCentral
Metadata
Title
Single metastasis of myxoid liposarcoma from the thigh to thyroid gland: a case report
Authors
Hiroshi Urakawa
Kenichi Nakanishi
Eisuke Arai
Kunihiro Ikuta
Shunsuke Hamada
Takehiro Ota
Naoki Ishiguro
Yoshihiro Nishida
Publication date
01-12-2018
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1370-1

Other articles of this Issue 1/2018

World Journal of Surgical Oncology 1/2018 Go to the issue